Updated Jul 16, 2026
BUCHAN JANE has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Jane Buchan is a biotech industry professional who, according to the most recent SEC filing dated 2026-05-29, serves as a Director of Immix Biopharma, Inc. No additional biographical details are provided in the filing context.
| Role | Director |
|---|---|
| Notability | 25/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-29 | IMMX | Immix Biopharma, Inc. | A — Grant or award | 6.2K | $0.00 |
Jane Buchan is a biotech industry professional who, according to the most recent SEC filing dated 2026-05-29, serves as a Director of Immix Biopharma, Inc. No additional biographical details are provided in the filing context.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live BUCHAN JANE profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.